1990
DOI: 10.1001/archderm.126.11.1454
|View full text |Cite
|
Sign up to set email alerts
|

MY7 monoclonal antibody for diagnosis of cutaneous T-cell lymphoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

2
1
0

Year Published

1992
1992
2011
2011

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 0 publications
2
1
0
Order By: Relevance
“…C onccrning the interest in My7 antigen tCDI3) to help in the diagnosis of early MF, in our series we observed that the expression of this antigen disappeared, mainly when the histological aspect was that of an epidermotropic CTCL, which is in agreement with former studies that showed a disappearance of the expression ofthe My7 antigen in cutaneous lymphomas (MF and Sezary's syndrome) (4,5). However, in our study the expression of this antigen also disappeared in 38 patients with PP with a non-histological aspect of MF.…”
Section: Discussionsupporting
confidence: 91%
See 1 more Smart Citation
“…C onccrning the interest in My7 antigen tCDI3) to help in the diagnosis of early MF, in our series we observed that the expression of this antigen disappeared, mainly when the histological aspect was that of an epidermotropic CTCL, which is in agreement with former studies that showed a disappearance of the expression ofthe My7 antigen in cutaneous lymphomas (MF and Sezary's syndrome) (4,5). However, in our study the expression of this antigen also disappeared in 38 patients with PP with a non-histological aspect of MF.…”
Section: Discussionsupporting
confidence: 91%
“…This study focused on 2 markers: the antigen CD13 and the T-eell reecptor. Indeed, previously, CDI3 (My7) has been identified as an antigen expressed by basal cells in normal skin, whose expression disappeared in epldermotropic cutaneous lymphomas: that is specific to My7 antigen and is not obtained with another CD 13 monoelonal antibody (4,5). This piienomenon is specific to epi derm otropic cutaneous T-eell lymphoma (CTCL).…”
mentioning
confidence: 99%
“…Other immunophenotypic features consistent with a T-cell lymphoblastic malignancy included CD7 positivity [47,481, cytoplasmic staining for CD3 [2], and nonreactivity with B-cell markers and myeloperoxidase. The finding of significant numbers of CD13-positive cells on flow cytometry is also consistent with a mixed AMPD/T-cell lesion, as this marker has been found on activated and malignant T lymphocytes [49,50] as well as myeloid cells. A more likely explanation is that TcR gene rearrangement did not occur, and T-cell development was arrested at the stage of assembly of the TcR-CD3 complex.…”
Section: Discussionsupporting
confidence: 77%